{
    "relation": [
        [
            "Company",
            "ALLEGIANT T\u2026",
            "SIMULATIONS\u2026",
            "BOOT BARN H\u2026",
            "AMEDISYS IN\u2026",
            "CAL-MAINE F\u2026"
        ],
        [
            "Symbol",
            "ALGT",
            "SLP",
            "BOOT",
            "AMED",
            "CALM"
        ],
        [
            "Price",
            "219.87",
            "6.66",
            "32.56",
            "44.88",
            "55.11"
        ],
        [
            "%Chg",
            "+3.36%",
            "+3.10%",
            "+3.04%",
            "+2.87%",
            "+1.75%"
        ]
    ],
    "pageTitle": "Questcor (QCOR) Misses on Q2 Earnings, Beats on Revenues - July 25, 2014 - Zacks.com",
    "title": "",
    "url": "http://www.zacks.com/stock/news/141443/questcor-qcor-misses-on-q2-earnings-beats-on-revenues",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 0,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042990609.0/warc/CC-MAIN-20150728002310-00242-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 844012423,
    "recordOffset": 843991281,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{14913=by Zacks Equity Research \u00a0\u00a0Published on July 25, 2014 |, 62686=At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm., 20256=Questcor Pharmaceuticals Inc. reported second quarter 2014 earnings per share of $1.71, up from the year-ago earnings of $1.25 per share. Excluding share- based compensation expense, one-time items and non-cash expenses, earnings stood at $1.85 per share., 21766=We note that Acthar, an injectable drug, has been approved by the U.S. Food and Drug Administration for as many as 19 indications. Questcor shipped 8,850 vials of Acthar during the second quarter of 2014, up 26.0% year over year., 22661=In Apr 2014, Questcor agreed to merge with Mallinckrodt (MNK - Analyst Report). As per the terms of the agreement, shareholders of Questcor will receive $30.00 per share in cash and 0.897 Mallinckrodt shares for each Questcor share held. Based on the closing price of Mallinckrodt on Jul 18, 2014, the total value comes to $6.3 billion. Mallinckrodt expects to complete the transaction in Aug 2014., 62625=Copyright \u00a9 2015 Zacks Investment Research, 21294=Second quarter 2014 revenues climbed 51% to $278.8 million, easily beating the Zacks Consensus Estimate of $264 million.}",
    "lastModified": "Tue, 04 Aug 2015 05:09:48 -0500",
    "textBeforeTable": "Income Momentum Value Growth Zacks #1 Rank Top Movers for Aug 4, 2015 Zacks #1 Rank Top Movers Zacks #1 Rank Top Movers for 08/04/15 } } document.getElementById('score_val').className = ''; document.getElementById('score_val').innerHTML = ''; document.getElementById('tab_label').innerHTML = tab_text; { else } document.getElementById('score_val').className = 'scores_val'; document.getElementById('score_val').innerHTML = 'A'; document.getElementById('tab_label').innerHTML = tab_text+ ' Score'; { if(tab_text != 'income') document.getElementById('rank_text').innerHTML = cat_uri; var cat_uri = 'View All Zacks Rank #1 '+tab_text+' Stocks'; var cat_uri = '/stocks/buy-list/'+tab_text; { function footer_text(tab_text)",
    "textAfterTable": "Company Symbol Price %Chg SKYWEST INC\u2026 SKYW 17.10 +3.26% PCM INC PCMI 10.29 +2.18% TRIUMPH BAN\u2026 TBK 14.25 +1.35% BOX SHIPS I\u2026 TEU 0.82 +1.29% EMPLOYERS H\u2026 EIG 24.30 +1.25% Company Symbol Price %Chg AMAG PHARMA\u2026 AMAG 66.20 +3.60% SKYWEST INC\u2026 SKYW 17.10 +3.26% AMEDISYS IN\u2026 AMED 44.88 +2.87% CAROLINA FI\u2026 CARO 16.40 +2.44%",
    "hasKeyColumn": true,
    "keyColumnIndex": 1,
    "headerRowIndex": 0
}